Market research
WEED.TO Canopy Growth Corporation
TO CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 575M
- P/E ratio
- Not available
- Analyst target
- 2.02
- Dividend yield
- Not available
- Beta
- 2.43
Profile
Company facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA1380357048
- Market cap
- 575M
- P/E ratio
- Not available
- Analyst target
- 2.02
- Dividend yield
- Not available
- Beta
- 2.43
About
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the WEED.TO discussion.
5 years, 5 months ago
Canopy Growth Corporation is currently in a long term downtrend where the price is trading 18.6% below its 200 day moving average.
From a valuation standpoint, the stock is 97.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 29.0.
Canopy Growth Corporation's total revenue rose by 23.2% to $153M since the same quarter in the previous year.
Its net income has dropped by 647.6% to $-904M since the same quarter in the previous year.
Finally, its free cash flow grew by 62.9% to $-135M since the same quarter in the previous year.
Based on the above factors, Canopy Growth Corporation gets an overall score of 3/5.